KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Change in Receivables (2016 - 2025)

Tenet Healthcare's Change in Receivables history spans 17 years, with the latest figure at $48.0 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 177.42% year-over-year to $48.0 million; the TTM value through Dec 2025 reached -$20.0 million, up 91.84%, while the annual FY2025 figure was -$20.0 million, 91.84% up from the prior year.
  • Change in Receivables for Q4 2025 was $48.0 million at Tenet Healthcare, up from -$28.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $263.0 million in Q1 2024 and bottomed at -$340.0 million in Q2 2024.
  • The 5-year median for Change in Receivables is $11.5 million (2021), against an average of $5.0 million.
  • The largest annual shift saw Change in Receivables soared 2120.0% in 2022 before it plummeted 1314.29% in 2024.
  • A 5-year view of Change in Receivables shows it stood at -$5.0 million in 2021, then skyrocketed by 2120.0% to $101.0 million in 2022, then crashed by 40.59% to $60.0 million in 2023, then tumbled by 203.33% to -$62.0 million in 2024, then surged by 177.42% to $48.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Change in Receivables are $48.0 million (Q4 2025), -$28.0 million (Q3 2025), and -$109.0 million (Q2 2025).